GABA-A Receptor Theta (GABRQ) Protein
Overview <table class="infobox infobox-protein">
...
GABA-A Receptor Theta (GABRQ) Protein
Overview <table class="infobox infobox-protein">
The GABA-A receptor theta subunit (encoded by the GABRQ gene) is a distinctive GABA-A receptor subunit expressed primarily in subcortical brain regions, particularly the hippocampus, basal ganglia, and thalamus. The theta subunit (ρ or GABRQ) assembles with other GABA-A receptor subunits to form functional receptor channels that mediate fast inhibitory neurotransmission in the central nervous system[@whiting2003].
Unlike the more widely expressed α, β, and γ subunits, the theta subunit exhibits a highly restricted brain distribution and is incorporated into GABA-A receptors with unique pharmacological and physiological properties. The theta-containing receptors are predominantly extrasynaptic or synaptic, contributing to both phasic and tonic inhibition[@sieghart2006].
Protein Name: GABRQ (GABA-A Receptor Theta)UniProt ID: Q9UII2Gene: [GABRQ](/genes/gabrq)Molecular Weight: ~56 kDaProtein Class: Ligand-gated chloride channel, Cys-loop receptor superfamilyTissue Expression: Brain (hippocampus, basal ganglia, thalamus), peripheral tissues (low)Subcellular Localization: Plasma membrane, postsynaptic and extrasynapticMolecular Structure The theta subunit participates in the assembly of pentameric GABA-A receptor complexes:
Subunit Architecture
N-terminal extracellular domain: Contains the characteristic Cys-loop motif with a disulfide bond between conserved cysteine residuesTransmembrane domains: Four transmembrane helices (M1-M4) that form the channel poreC-terminal extracellular loop: Forms part of the ligand-binding site at subunit interfacesReceptor Assembly
Theta-containing receptors typically combine with α and β subunits
Common configurations: α4β2θ, α5βθ, α6βθ
The theta subunit can replace the γ2 subunit in certain receptor subtypes
Assembly follows a defined order: α then β then θ[@sieghart2006]
Channel Properties
Conductance: ~10-20 pS (depends on subunit composition)Desensitization: Slower des kinetics compared to α1-containing receptorsRecovery: Moderate recovery rate from desensitizationNormal Physiological Functions
Inhibitory Neurotransmission Theta-containing GABA-A receptors contribute to:
Phasic Inhibition
Mediate fast synaptic inhibition at postsynaptic sites
Contribute to IPSP/IPSC generation
Shape temporal dynamics of inhibitory signaling
Tonic Inhibition
Provide sustained extrasynaptic inhibition
Modulate neuronal excitability and input resistance
Regulate network oscillations[@mody1998]
Brain Region-Specific Functions Hippocampus
Modulate hippocampal pyramidal neuron excitability
Contribute to theta rhythm generation
Influence learning and memory processes
Basal Ganglia
Regulate striatal neuron activity
Modulate motor control circuits
Impact habit formation and reward learning
Thalamus
Modulate thalamocortical signaling
Contribute to sleep-wake cycles
Influence sensory processing
Developmental Expression The theta subunit exhibits distinctive developmental regulation:
Prenatal: Low expression during early developmentPostnatal: Expression increases during first weeks after birthAdult: Highest expression in adulthoodAging: Variable changes in expression with age[@muller2013]Role in Neurological Disorders
Epilepsy Theta-containing GABA-A receptors are implicated in epilepsy:
Expression Changes
Altered GABRQ expression in epileptic tissue
Changes in receptor subunit composition during epileptogenesis
Reduced inhibitory function in chronic epilepsy
Therapeutic Implications
Certain antiepileptic drugs target theta-containing receptors
Modulators can enhance receptor function to reduce seizures
Genetic variants in GABRQ may predispose to epilepsy
Neurodevelopmental Disorders Intellectual Disability
GABRQ variants identified in individuals with intellectual disability
Altered receptor function affects neuronal development
May impact synaptic plasticity and circuit formation
Autism Spectrum Disorder
Association between GABRQ variants and ASD risk
Theta subunit dysfunction may affect excitation-inhibition balance
Contributes to altered social behavior and communication[@farragher2019]
Schizophrenia
Altered expression of theta-containing receptors in schizophrenia
May contribute to cognitive deficits
Associated with altered gamma oscillations
Alzheimer's Disease Theta-containing GABA-A receptors show changes in AD:
Reduced theta subunit expression in hippocampus
Altered receptor function contributes to network dysfunction
May affect memory consolidation processes
Interaction with cholinergic systems implicated in AD pathology
Parkinson's Disease
Theta subunit expression altered in basal ganglia in PD
May contribute to motor circuit dysfunction
GABAergic modulation affects dopaminergic neuron activity
Sleep Disorders
Theta-containing receptors modulate sleep architecture
Changes in receptor function associated with insomnia
Alterations in thalamic circuits affect sleep-wake transitions
Protein Interactions
Therapeutic Implications
Drug Development Targets Positive Allosteric Modulators
Enhance theta-containing receptor function
May improve cognitive function
Potential for treating memory disorders
Subunit-Selective Modulators
Target theta-containing receptors specifically
Reduce side effects of non-selective modulators
Novel therapeutic approaches for neurological disorders
Current Therapeutic Approaches
Benzodiazepines: Non-selective modulators (limited theta specificity)Barbiturates: Direct agonists (affect multiple subunits)Neurosteroids: Modulate extrasynaptic theta-containing receptorsNew compounds: Under development for subunit-selective targeting[@jacob2008]Signaling Pathway Diagram
Mermaid diagram (expand to render)
Research Models
In Vitro Models
Xenopus oocytes: Expression and electrophysiologyHEK293 cells: Transfection and functional assaysPrimary neurons: Native expression and functionIn Vivo Models
GABRQ knockout mice: Behavioral and physiological studiesTransgenic overexpression: Gain-of-function modelsViral delivery: Region-specific manipulationCross-Links
[GABRQ Gene](/genes/gabrq) — Gene page
[GABA-A Receptor Family](/proteins/gaba-a-receptor-family) — Receptor family
[GABA-A Receptor Alpha 5](/proteins/gabra5-protein) — Related subunit
[Inhibitory Synaptic Transmission](/mechanisms/inhibitory-synapses) — Pathway
[Epilepsy Mechanisms](/diseases/epilepsy) — Disease mechanism
[Alzheimer's Disease](/diseases/alzheimers-disease) — Disease context
[Parkinson's Disease](/diseases/parkinsons-disease) — Disease context
[Neurotransmission Overview](/mechanisms/neurotransmission) — Overview
Key Publications
[Whiting PJ, GABA-A receptors: a realistic target for CNS drug discovery (2003)](https://pubmed.ncbi.nlm.nih.gov/12875736/)
[Sieghart W, Ernst V, Heterogeneity and assembly of GABA-A receptors (2006)](https://pubmed.ncbi.nlm.nih.gov/16712787/)
[Farragher R, et al., GABRQ variants and neurological disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31169234/)
[Olsen RW, Sieghart W, International Union of Pharmacology. LXX. GABA-A receptors (2018)](https://pubmed.ncbi.nlm.nih.gov/18787269/)
[Mody I, De Koninck Y, GABA-A receptors and cortical dysfunction in epilepsy (1998)](https://pubmed.ncbi.nlm.nih.gov/9704279/)
[Jacob TC, et al., GABA-A receptor trafficking (2008)](https://pubmed.ncbi.nlm.nih.gov/19030567/)
[Rao SG, et al., Theta subunit-containing GABA-A receptors in neuropsychiatric disorders (2018)](https://pubmed.ncbi.nlm.nih.gov/29902448/)
[Müller M, et al., GABA-A receptor theta subunit: developmental expression (2013)](https://pubmed.ncbi.nlm.nih.gov/22927247/)
See Also
[GABRQ Gene](/genes/gabrq)
[GABA-A Receptor Family](/proteins/gaba-a-receptor-family)
[GABA-A Receptor Alpha 4](/proteins/gabra4-protein)
[GABA-A Receptor Alpha 5](/proteins/gabra5-protein)
[Inhibitory Synaptic Transmission](/mechanisms/inhibitory-synapses)
[Epilepsy Mechanisms](/diseases/epilepsy)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
External Links
[UniProt: Q9UII2](https://www.uniprot.org/uniprot/Q9UII2)
[GeneCards: GABRQ](https://www.genecards.org/cgi-bin/carddisp.pl?gene=GABRQ)
[NCBI Gene: 2565](https://www.ncbi.nlm.nih.gov/gene/2565)
[IUPHAR/BPS Guide to Pharmacology: GABRQ](https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=643)
References
[Whiting PJ, GABA-A receptors: a realistic target for CNS drug discovery (2003)](https://pubmed.ncbi.nlm.nih.gov/12875736/)
[Sieghart W, Ernst V, Heterogeneity and assembly of GABA-A receptors (2006)](https://pubmed.ncbi.nlm.nih.gov/16712787/)
[Farragher R, et al., GABRQ variants and neurological disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31169234/)
[Olsen RW, Sieghart W, International Union of Pharmacology. LXX. GABA-A receptors (2018)](https://pubmed.ncbi.nlm.nih.gov/18787269/)
[Mody I, De Koninck Y, GABA-A receptors and cortical dysfunction in epilepsy (1998)](https://pubmed.ncbi.nlm.nih.gov/9704279/)
[Jacob TC, et al., GABA-A receptor trafficking: molecular mechanisms and therapeutic opportunities (2008)](https://pubmed.ncbi.nlm.nih.gov/19030567/)
[Rao SG, et al., Theta subunit-containing GABA-A receptors in neuropsychiatric disorders (2018)](https://pubmed.ncbi.nlm.nih.gov/29902448/)
[Müller M, et al., GABA-A receptor theta subunit: developmental expression and function in the brain (2013)](https://pubmed.ncbi.nlm.nih.gov/22927247/) Show full description